Prognostic Stage IIIC Breast Cancer AJCC v8 (DBCOND0109638)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03872388
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapytreatment2terminated
NCT05049746
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant ChemotherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT05092373
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thoraxtreatment1recruiting
NCT05025059
Exercise During Chemotherapy in Older Women with Stage I-III Breast CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04139993
RBX7455 Before Surgery for the Treatment of Operable Breast CancerNo drug interventionstreatment1terminated
NCT04876378
Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and HandNo drug interventionsNot AvailableNot Availableterminated
NCT05674578
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT05243056
A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT04862585
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxelsupportive_care2 / 3completed
NCT04927559
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT03725436
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumorstreatment1active_not_recruiting
NCT03666819
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal AtrophyNo drug interventionstreatment2withdrawn
NCT05244434
Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerNo drug interventionsbasic_scienceNot Availablewithdrawn
NCT04871516
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05455658
STEMVAC in Patients With Early Stage Triple Negative Breast Cancerprevention2recruiting
NCT04454086
Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT04560439
Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer SurvivorsNo drug interventionsotherNot Availablewithdrawn
NCT04249622
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancertreatment2active_not_recruiting
NCT04705025
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNo drug interventionssupportive_careNot Availableterminated
NCT04999826
Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer SurvivorsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04329065
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancertreatment2recruiting
NCT02918474
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT04498520
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancertreatment1withdrawn
NCT04771520
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumorstreatment2recruiting
NCT04200482
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsNo drug interventionssupportive_care2completed
NCT05319873
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancertreatment1 / 2recruiting
NCT05012176
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04001829
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancersupportive_care2active_not_recruiting
NCT04090567
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancertreatment2recruiting
NCT03132467
Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancertreatment0completed
NCT03620201
M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancertreatment1active_not_recruiting
NCT03774472
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancertreatment1 / 2completed
NCT04216472
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterationstreatment2active_not_recruiting
NCT04754412
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumorstreatment1 / 2recruiting
NCT05452681
A QoL Intervention for Young African American Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT03523195
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT05417308
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancertreatment0recruiting
NCT03291938
IACS-010759 in Advanced CancersNo drug interventionstreatment1completed
NCT04205903
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancertreatment1recruiting
NCT01334021
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast CancerNo drug interventionsdiagnostic2active_not_recruiting
NCT03786354
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05071677
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03106077
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancertreatment2completed
NCT04835597
Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT05368428
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT03505671
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04549571
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider InterventionsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04205071
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancertreatment1withdrawn
NCT04906200
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT03715959
Nipple Aspirate Fluid in Detecting Breast CancerNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT04086875
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03518242
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancertreatment1completed
NCT03751449
Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availableterminated
NCT03505736
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerNot AvailableNot Availablecompleted
NCT05177796
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancertreatment2withdrawn
NCT04457596
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trialtreatment3recruiting
NCT04294225
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancertreatment2completed
NCT02971748
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapytreatment2active_not_recruiting
NCT03218826
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgerytreatment1active_not_recruiting
NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04716920
Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialNo drug interventionssupportive_careNot Availablecompleted
NCT05086731
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast CancerNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT04067960
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNo drug interventionsscreening0completed
NCT03207529
Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancertreatment1completed
NCT03554044
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancertreatment1active_not_recruiting
NCT06324240
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancertreatment1not_yet_recruiting
NCT04249167
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancertreatment0withdrawn
NCT03939481
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04678414
Infertility Survey Among Reproductive Age Women With Gynecological and Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00507923
Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04535323
Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancersupportive_care1completed
NCT03979508
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancertreatment2recruiting